CDH2 and hepatocellular carcinoma: In HCC, β-catenin further downregulates E-cadherin (an inhibitory factor of β-catenin), upregulates N-cadherin and vimentin (pro LGR5 and CD44 also maintain cancer stem cell (CSC) population and resulting in chemoresistance and recurrence [46].